Assyro AI

FDA Orange Book · active-ingredient family

Dextrose; potassium chloride; sodium chloride

Dextrose; potassium chloride; sodium chloride is approved as 10 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

10

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER×2FRESENIUS KABI USAANDA 212348APJul 30, 2021
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%×5FRESENIUS KABI USAANDA 213523APMar 09, 2021
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%×2FRESENIUS KABI USAANDA 213445APMar 09, 2021

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Dextrose; potassium chloride; sodium chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.